Peripheral Neuropathy Trial, Recruiting (NCT04448938)

Peripheral Neuropathy Trial, Recruiting NCT04448938 Sponsor: Fondation Ophtalmologique Adolphe de Rothschild Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT04448938 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 years or older
People where optic neuritis (inflammation of the optic nerve) is suspected by their doctor
People who are already scheduled to have an MRI scan to investigate possible optic neuritis
People who are covered by a social security (health insurance) scheme
People who have been fully informed about the study and have given their written consent to take part

Who may not be able to join:

People for whom an MRI scan is not safe or not recommended, including women who are pregnant or breastfeeding
People with a history of amblyopia (sometimes called "lazy eye")
People who have a pre-existing condition that already affects their vision, such as retinitis pigmentosa or age-related macular degeneration (AMD)
People who are under a legal protection measure (such as guardianship or court-appointed supervision) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04448938

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

More information: https://clinicaltrials.gov/study/NCT04448938

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 years or older
People where optic neuritis (inflammation of the optic nerve) is suspected by their doctor
People who are already scheduled to have an MRI scan to investigate possible optic neuritis
People who are covered by a social security (health insurance) scheme
People who have been fully informed about the study and have given their written consent to take part

Who may not be able to join:

People for whom an MRI scan is not safe or not recommended, including women who are pregnant or breastfeeding
People with a history of amblyopia (sometimes called "lazy eye")
People who have a pre-existing condition that already affects their vision, such as retinitis pigmentosa or age-related macular degeneration (AMD)
People who are under a legal protection measure (such as guardianship or court-appointed supervision) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Registry

ClinicalTrials.gov

Start date

17 December 2020

Est. completion

1 December 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

The ophthalmological functional recovery will be assessed by measuring the low contrast visual acuity on the Early Treatment Diabetic Retinopathy study scale (ETDRS scale).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov